They demonstrated that the genotype and the frequency of alleles of the MMP-9-1562C/T polymorphism does not differ significantly between the GBS patients and the healthy subjects (p = 0.665 and p = 0.479, respectively). This evidence concerns the gene MMP9 and Guillain-Barre syndrome.